
Chicago Atlantic BDC, Inc.
LIENNasdaqCIK 1843162OtherFiscal year ends Dec 31
Reports and events: 81 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-2322:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950103-24-002723 |
| 2024-02-2012:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-24-002396 |
| 2023-11-0921:58 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-23-016145 |
| 2023-11-0921:51 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001140361-23-052491 |
| 2023-10-2620:41 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-23-015413 |
| 2023-09-0623:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-23-013270 |
| 2023-08-1111:45 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001140361-23-039188 |
| 2023-08-1110:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-23-011885 |
| 2023-07-2616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-23-010787 |
| 2023-06-2318:00 ET | 8-K | 5.07 Shareholder vote results | 0000950103-23-009160 |
| 2023-05-1211:50 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001140361-23-024271 |
| 2023-05-1200:19 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-23-007200 |
| 2023-05-0922:13 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-23-006995 |
| 2023-04-2818:38 ET | DEF 14A | Proxy statementPeriod 2023-06-21 | 0001140361-23-021432 |
| 2023-03-3101:56 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-23-005091 |
| 2023-03-0922:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-23-003908 |
| 2023-03-0722:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950103-23-003799 |
| 2023-01-2622:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-23-001126 |
| 2022-11-1519:49 ET | 8-K | 5.03 Amendment to articles or bylaws | 0000950103-22-019682 |
| 2022-11-1021:16 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-22-019508 |
| 2022-11-1021:15 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001140361-22-040935 |
| 2022-11-0115:25 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-22-018842 |
| 2022-09-2215:02 ET | 8-K | 5.07 Shareholder vote results | 0000950103-22-016217 |
| 2022-08-1721:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950103-22-014137 |
| 2022-08-1223:43 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001140361-22-029320 |
| 2022-07-2917:57 ET | DEF 14A | Proxy statementPeriod 2022-09-21 | 0001140361-22-027396 |
| 2022-06-3020:11 ET | 10-K/A | Annual report, amendedPeriod 2022-03-31 | 0000950103-22-011767 |
| 2022-06-2921:21 ET | 10-K | Annual reportPeriod 2022-03-31 | 0000950103-22-011631 |
| 2022-06-0313:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-22-010081 |
| 2022-03-0122:30 ET | 8-K | 8.01 Other events | 0000950103-22-003721 |
| 2022-02-0901:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-22-002251 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.